Main Menu

Ebola Vaccine to be Available by 2018

A highly effective vaccine that guards against the deadly Ebola virus could be available by 2018, says the World Health Organization.

Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans.
The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.

Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show it offers 100% protection.

The WHO’s Marie-Paule Kieny said the results could help combat future outbreaks. “While these compelling results come too late for those who lost their lives during West Africa’s Ebola epidemic, they show that when the next Ebola outbreak hits, we will not be defenceless,” said Dr Kieny, the lead author of the study.
Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show it offers 100% protection.
The vaccine is now being fast-tracked for regulatory approval.
Manufacturer Merck has made 300,000 doses of the rVSV-ZEBOV vaccine available for use should Ebola strike.
GAVI, the global vaccine alliance, provided $5m for the stockpile.

Other drug companies are developing different Ebola vaccines that could be used in the future too.

Ebola has been around for 40 years now. However the West African Ebola virus epidemic (2013–2016) was the most widespread outbreak of Ebola virus disease in history—causing major loss of life and socioeconomic disruption in the region, mainly in the countries of Guinea, Liberia, and Sierra Leone.

It was until this devastating outbreak of the disease  in West Africa that the world decided to invest some serious money into finding treatments and cures.






Leave a Reply

Your email address will not be published. Required fields are marked as *

*